Trial Profile
Study of patient outcomes with myelofibrosis treated with compassionate use pacritinib
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Pacritinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Expanded access
- 27 Jul 2018 Results (n=19) published in the Annals of Hematology
- 27 Jul 2018 New trial record